What is AcuityMD?
Founded in 2019, AcuityMD specializes in creating innovative healthcare software solutions that bring clarity to the products used in patient treatment. Their platform is instrumental for medical device companies, enabling them to broaden access within their respective markets. The software facilitates collaboration across sales, marketing, medical education, and product development teams. By recording product usage, analyzing outcome variations, and identifying opportunities for physicians and care sites, AcuityMD empowers medical device companies to optimize patient care and market engagement. The company's focus on data-driven insights positions it as a key player in the digital health transformation.
How much funding has AcuityMD raised?
AcuityMD has raised a total of $163M across 4 funding rounds:
Other Financing Round
$7M
Series A
$31M
Series B
$45M
Series C
$80M
Other Financing Round (2021): $7M with participation from Benchmark and Ajax Health
Series A (2022): $31M led by Ajax Health, Artisanal Ventures, Benchmark, and Redpoint Venture Partners
Series B (2024): $45M supported by ICONIQ Growth, Atreides Management, and StepStone Group
Series C (2026): $80M featuring Benchmark, Redpoint Ventures, ICONIQ Capital, Atreides Management, and StepStone Group
Key Investors in AcuityMD
ICONIQ Growth
ICONIQ Growth is a venture capital firm that partners with exceptional entrepreneurs and leaders to drive global impact. They focus on building enduring company cultures and leverage a vibrant ecosystem of founders and business leaders to amplify portfolio company success from early growth stages through IPO.
Atreides Management
Atreides Management is an investment firm founded in 2019, focusing on long-term investments in technology and consumer businesses across both public and private markets.
StepStone Group
StepStone Group is a global private markets investment firm providing customized investment solutions and advisory services to institutional clients, including pension funds, sovereign wealth funds, and endowments.
What's next for AcuityMD?
The recent major strategic investment in AcuityMD signals a pivotal phase for the company, likely focused on accelerating product development, expanding its sales and marketing reach, and potentially exploring new market segments. With a robust funding history, AcuityMD is well-positioned to further enhance its collaboration software for medical device companies. Future initiatives may include deeper integration with existing healthcare systems, advanced analytics for outcome prediction, and strategic partnerships to broaden its impact on patient care delivery and market penetration. The company's trajectory suggests a continued emphasis on innovation and market leadership within the healthcare technology landscape.
See full AcuityMD company page
